Hervé Bonnefoi Selected Research

Hervé Bonnefoi Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 12/2023 - 05/2003
14	Neoplasms (Cancer) 10/2022 - 01/2007
7	Triple Negative Breast Neoplasms 12/2023 - 07/2014
3	Fatigue 11/2023 - 10/2017
2	Vomiting 01/2020 - 10/2017
2	Residual Neoplasm 01/2020 - 01/2016
2	Nausea 01/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 08/2017 - 01/2007
1	Pathologic Complete Response 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Lobular Carcinoma 01/2021
1	Ductal Carcinoma 01/2021
1	Constipation 01/2020
1	Breast Diseases (Breast Disease) 01/2020
1	Headache (Headaches) 10/2017
1	Asthenia 10/2017
1	Diarrhea 10/2017
1	Infections 01/2017
1	Thrombotic Microangiopathies 01/2016
1	Inflammatory Breast Neoplasms 01/2016
1	Obesity 11/2012
1	Carcinogenesis 01/2007
1	Lymphatic Metastasis 01/2004

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 11/2023 - 07/2014
10	Trastuzumab (Herceptin)FDA Link 10/2023 - 03/2009
8	taxaneIBA 10/2023 - 01/2004
8	human ERBB2 proteinIBA 01/2023 - 01/2017
7	ErbB Receptors (EGF Receptor)IBA 11/2023 - 01/2017
7	Estrogen ReceptorsIBA 11/2021 - 01/2009
5	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 11/2018
5	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2016
4	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2015
4	pertuzumabIBA 10/2023 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 11/2015
3	AnthracyclinesIBA 10/2022 - 06/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2014
3	Letrozole (Femara)FDA LinkGeneric 02/2021 - 11/2012
3	Tamoxifen FDA LinkGeneric 02/2021 - 11/2012
3	Fulvestrant (Faslodex)FDA Link 01/2020 - 08/2015
2	durvalumabIBA 12/2023 - 11/2023
2	palbociclibIBA 11/2023 - 10/2021
2	Taxoids (Taxanes)IBA 10/2022 - 06/2011
2	Ado-Trastuzumab EmtansineIBA 10/2022 - 01/2020
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2020 - 08/2015
2	iniparibIBA 09/2019 - 11/2015
2	Gemcitabine FDA Link 09/2019 - 11/2015
2	Abiraterone AcetateIBA 01/2019 - 11/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2017 - 03/2009
2	Docetaxel (Taxotere)FDA Link 06/2011 - 12/2007
2	Epirubicin (Ellence)FDA LinkGeneric 06/2011 - 12/2007
2	Fluorouracil (Carac)FDA LinkGeneric 06/2011 - 12/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011 - 12/2007
1	Androgen Antagonists (Antiandrogens)IBA 12/2023
1	Maytansine (Maitansine)IBA 10/2023
1	Aromatase InhibitorsIBA 02/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 10/2017
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2017
1	NucleotidesIBA 08/2017
1	LigandsIBA 01/2017
1	InterferonsIBA 01/2017
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2017
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Biological FactorsIBA 12/2013
1	Estrogen Receptor alphaIBA 01/2007

Therapy/Procedure

18	Neoadjuvant Therapy 01/2023 - 12/2007
14	Therapeutics 11/2023 - 09/2004
9	Drug Therapy (Chemotherapy) 10/2023 - 05/2003
4	Adjuvant Chemotherapy 02/2019 - 01/2016
2	Radiotherapy 01/2022 - 01/2004
2	Mastectomy (Mammectomy) 01/2022 - 04/2015
2	Mammaplasty (Breast Reconstruction) 01/2022 - 01/2007
1	Immunotherapy 11/2023
1	Aftercare (After-Treatment) 08/2015
1	Segmental Mastectomy (Lumpectomy) 08/2015
1	Lymph Node Excision (Lymph Node Dissection) 01/2004